Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
October 13, 2007
Phyllodes tumor of the breast
Yazid Belkacémi, Guilhem Bousquet, Hugo Marsiglia, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 30, 2009
Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancer
James W Denham, Mahesh Kumar, Paul S Gleeson, et al.
Histopathology
|
April 15, 2020
Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial
Brett Delahunt, Judith D Murray, Allison Steigler, et al.
Scientific Reports
|
October 29, 2024
Mapping the sources and strands of marine debris via particle modelling and In-situ sampling approaches in archipelagic countries
Noir P Purba, Ibnu Faizal, David Christie, et al.
The Lancet. Oncology
|
November 16, 2012
Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial
James W Denham, Chantelle Wilcox, David Joseph, et al.
The Oncologist
|
February 26, 2014
Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study)
Marta Bruno Ventre, Andrés J M Ferreri, Mary Gospodarowicz, et al.
Breast (Edinburgh, Scotland)
|
July 4, 2007
Turning subjective into objective: the BCCT.core software for evaluation of cosmetic results in breast cancer conservative treatment
Maria João Cardoso, Jaime Cardoso, Natália Amaral, et al.
British Journal of Haematology
|
January 4, 2014
Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study)
Carlo Messina, Andrés J M Ferreri, Silvia Govi, et al.
The Lancet. Oncology
|
December 24, 2018
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial
James W Denham, David Joseph, David S Lamb, et al.
The Lancet. Oncology
|
August 19, 2014
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial
James W Denham, David Joseph, David S Lamb, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
International Journal of Radiation Oncology, Biology, Physics
|
October 13, 2007
Phyllodes tumor of the breast
Yazid Belkacémi, Guilhem Bousquet, Hugo Marsiglia, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 30, 2009
Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancer
James W Denham, Mahesh Kumar, Paul S Gleeson, et al.
Histopathology
|
April 15, 2020
Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial
Brett Delahunt, Judith D Murray, Allison Steigler, et al.
Scientific Reports
|
October 29, 2024
Mapping the sources and strands of marine debris via particle modelling and In-situ sampling approaches in archipelagic countries
Noir P Purba, Ibnu Faizal, David Christie, et al.
The Lancet. Oncology
|
November 16, 2012
Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial
James W Denham, Chantelle Wilcox, David Joseph, et al.
The Oncologist
|
February 26, 2014
Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study)
Marta Bruno Ventre, Andrés J M Ferreri, Mary Gospodarowicz, et al.
Breast (Edinburgh, Scotland)
|
July 4, 2007
Turning subjective into objective: the BCCT.core software for evaluation of cosmetic results in breast cancer conservative treatment
Maria João Cardoso, Jaime Cardoso, Natália Amaral, et al.
British Journal of Haematology
|
January 4, 2014
Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study)
Carlo Messina, Andrés J M Ferreri, Silvia Govi, et al.
The Lancet. Oncology
|
December 24, 2018
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial
James W Denham, David Joseph, David S Lamb, et al.
The Lancet. Oncology
|
August 19, 2014
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial
James W Denham, David Joseph, David S Lamb, et al.
Page
of 6